Sign Up Now!
To sign up for our newsletter or print publications, enter your contact information below.
First Name
Last Name
Address
Address (Continued)
City
State/Province
ZIP/Postal Code
Country
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegowina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos Keeling Islands
Colombia
Comoros
Congo
Congo, Democratic Republic of the
Cook Islands
Costa Rica
Cote d'Ivoire
Croatia Hrvatska
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands Malvinas
Faroe Islands
Fiji
Finland
France
France, Metropolitan
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Jamaica
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Kitts and Nevis
Saint LUCIA
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovakia (Slovak Republic)
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
St. Helena
St. Pierre and Miquelon
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands (British)
Virgin Islands (U.S.)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zambia
Zimbabwe
Print Edition
E-Newsletters & Communications
I have reviewed and consent to the terms of
TON
's
Privacy Policy
, and
TON
has my permission to retain my information in its database, and to forward pertinent communications to me.
Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe
Home
Issues
2019
April 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
2018
November 2018 - Vol 11 No 5
September 2018 - Vol 11 No 4
July 2018 - Vol 11 No 3
May 2018 - Vol 11 No 2
March 2018 - Vol 11 No 1
2017
November 2017 - Vol 10 No 6
September 2017 - Vol 10 No 5
July 2017 - Vol 10 No 4
May 2017 - Vol 10 No 3
March Vol 10 No 2
January Vol 10 No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ESMO 2018
ESMO 2018 Wrap-Up
HNF 2018
ASH 2017 - ITP
SABCS 2017 - Breast Cancer
ONS 2017 - Immunotherapy
ASH 2016 - Roundup
ASH 2016 - Multiple Myeloma
ASH 2015 - Multiple Myeloma
Web Exclusives
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Online First
Press Releases
Media Library
Videos
TON Interview with the Innovators Series
Audiocasts
Quick Quiz
CE
About
About TON
Contact Us
Editorial Board
Advertise
Resources
For Authors
Author Guidelines
Wayne Kuznar
Authored Items
Updated NCCN Treatment Guideline for CML Establishes Criteria for Stopping TKI Therapy
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
NCCN Updates
Immunotherapy Strategies in the Updated NCCN Guideline for NSCLC Hinge on PD-L1 Testing
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
NCCN Updates
Updated NCCN Breast Cancer Guideline Expands Treatment Recommendations for HR-Positive, HER2-Negative Disease
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
NCCN Updates
Immunotherapy Combination Extends Survival in Advanced Refractory Colorectal Cancer
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
Colorectal Cancer
Tumor Metabolism-Altering Regimen Achieves Clinical Benefit in Metastatic Pancreatic Cancer
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
Pancreatic Cancer
CAR T-Cell Therapy Fills Unmet Needs in Leukemia and Lymphoma
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
Immunotherapy
Genomic Markers of Response Improve Patient Selection for Immune Checkpoint Inhibitor Therapy
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
Immunotherapy
CAR T-Cell Therapy Associated with Unique, Acute Adverse Events Requiring Vigilant Monitoring
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
Immunotherapy
Immunotherapy Moving into Earlier Lines of Lung Cancer Therapy
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
Lung Cancer
Personalizing Immunotherapy in NSCLC Using PD-L1 and Tumor Mutation Burden as Biomarkers
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
Lung Cancer
Personalized Neoadjuvant Immunotherapy Combinations Improve Outcomes in Stage III Melanoma
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
Melanoma
Adding PARP Inhibitor to Immune Checkpoint Blockade Improves Responses in Ovarian Cancer with BRCA Mutations
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
Ovarian Cancer
Sacituzumab, a Novel Antibody-Drug Conjugate, Shows Activity in Heavily Pretreated Urothelial Cancer
Wayne Kuznar
TOP - May 2019, Vol 12, No 2
in
Urothelial Cancer
Luspatercept, First-in-Class Erythroid Maturation Agent, Reduces Transfusions in Patients with Low-Risk MDS
Wayne Kuznar
TON - April 2019, Vol 12, No 2
Nivolumab-Ipilimumab Combination Highly Active in Metastatic MSI-H or dMMR Colorectal Cancer
Wayne Kuznar
TON - February 2019, Vol 12, No 1
in
Colorectal Cancer
First-Line Ibrutinib Improves Outcomes Compared with Current Standard of Care in Older Patients with Chronic Lymphocytic Leukemia
Wayne Kuznar
TON - February 2019, Vol 12, No 1
in
Leukemia
Avelumab plus Axitinib Combination Improves Outcomes in Advanced Renal-Cell Carcinoma
Wayne Kuznar
TOP - February 2019, Vol 12, No 1
in
Immunotherapy
,
Renal-Cell Carcinoma
Investigational CAR T-Cell Therapy, bb2121, Shows Durable Responses in Relapsed or Refractory Multiple Myeloma
Wayne Kuznar
TON - November 2018, Vol 11, No 5
in
Immunotherapy
High Tumor Microsatellite Instability a Marker for Lynch Syndrome, More Common Condition Than Generally Expected
Wayne Kuznar
TON - September 2018, Vol 11, No 4
in
Lynch Syndrome
Regorafenib Dose-Escalation Strategy Potentially a New Standard in Metastatic Colorectal Cancer
Wayne Kuznar
TOP - August 2018, Vol 11, No 2
in
Colorectal Cancer
Immunotherapy Combination Shows Durable Responses in Mismatch Repair–Deficient Metastatic Colorectal Cancer
Wayne Kuznar
TOP - August 2018, Vol 11, No 2
in
Immunotherapy
Ivosidenib, New IDH1 Inhibitor, Elicits Complete Response in Relapsed Acute Myeloid Leukemia
Wayne Kuznar
TON - March 2018, Vol 11, No 1
in
Conference Correspondent
,
Drug Updates
,
ASH
Quizartinib Combinations Show High Activity in Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation
Wayne Kuznar
TON - March 2018, Vol 11, No 1
in
Conference Correspondent
,
Drug Updates
Selecting Optimal Therapy for Chronic Lymphocytic Leukemia Is a Work in Progress
Wayne Kuznar
TON - November 2017, Vol 10, No 6
in
Leukemia
Cediranib-Based Combination Therapy Extends Progression-Free Survival in Relapsed Ovarian Cancer
Wayne Kuznar
TOP - November 2017, Vol 10, No 4
in
Gynecologic Cancers
,
Online First
Olaparib First PARP Inhibitor to Show Advantage in BRCA-Positive Breast Cancers
Wayne Kuznar
TOP - November 2017, Vol 10, No 4
in
Breast Cancer
Osimertinib Extends Progression-Free Survival in EGFR T790M–Positive Lung Cancer with CNS Metastases Myeloma
Wayne Kuznar
TOP - November 2017, Vol 10, No 4
in
Lung Cancer
Updated NCCN Guidelines for Neuroendocrine Tumors and Carcinoid Syndrome Features New Therapies
Wayne Kuznar
TOP - August 2017, Vol 10, No 3
in
Conference Correspondent
,
NCCN News
Duloxetine Improves Chemotherapy-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer
Wayne Kuznar
TOP - May 2017, Vol 10, No 2
in
Pancreatic Cancer
Direct Access to Colonoscopy Improves Screening Rates, Adenoma Detection
Wayne Kuznar
TON - March 2017, Vol 10, No 2
in
Colorectal Cancer
Daily Moderate Exercise Can Improve Outcomes in Patients with Metastatic Colorectal Cancer
Wayne Kuznar
TON - March 2017, Vol 10, No 2
in
Colorectal Cancer
Internet-Generated Survivorship Care Plans Are Convenient and Customized
Wayne Kuznar
TON - March 2017, Vol 10, No 2
in
Survivorship
Duloxetine Improves Chemotherapy-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer
Wayne Kuznar
TON - March 2017, Vol 10, No 2
in
Rare Cancers
Venetoclax plus Bortezomib and Dexamethasone Produces High Responses in Relapsed or Refractory Multiple Myeloma
Wayne Kuznar
Web Exclusives
in
Conference Correspondent
,
In the News
Glasdegib, a Hedgehog Inhibitor, Nearly Doubles Survival in Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Wayne Kuznar
Web Exclusives
in
Conference Correspondent
,
In the News
Alectinib for First-Line Treatment in NSCLC with ALK Mutation
Wayne Kuznar
TOP - November 2016, Vol 9, No 4
in
Conference Correspondent
Minor Changes in Systemic Therapy Recommendations in NCCN Breast Cancer Guideline
Wayne Kuznar
TOP - August 2016, Vol 9, No 3
in
Guidelines
NCCN Survivorship Guidelines Update Management of Sexual Dysfunction in Cancer Survivors
Wayne Kuznar
TOP - August 2016, Vol 9, No 3
in
Guidelines
Promising Antitumor Activity of ODM-201 in Metastatic Prostate Cancer
Wayne Kuznar
TOP - August 2016, Vol 9, No 3
in
Genitourinary Cancers
NCCN Survivorship Guidelines Update Management of Sexual Dysfunction
Wayne Kuznar
TON July 2016 Vol 9 No 4
in
Guidelines
NCCN Panel Addresses Palliative Care Needs, Emphasizes Team Approach
Wayne Kuznar
TON July 2016 Vol 9 No 4
in
Palliative Care
Steroid Mouth Rinse Prevents Stomatitis with Everolimus
Wayne Kuznar
TON May 2016 Vol 9 No 3
in
Breast Cancer
Scan Underutilized in BRCA Carriers Undergoing Risk-Reducing Salpingo-Oophorectomy
Wayne Kuznar
TON May 2016 Vol 9 No 3
in
Conference Correspondent
Scalp Cooling System Lessens Chemotherapy-Induced Alopecia
Wayne Kuznar
TON May 2016 Vol 9 No 3
in
Breast Cancer
Text Messaging Application Helpful with Adherence to Endocrine Therapy
Wayne Kuznar
TOP - May 2016, Vol 9, No 2
in
Technology Update
Text Messaging Application Helpful with Adherence to Endocrine Therapy
Wayne Kuznar
TON March 2016 Vol 9 No 2
in
Technology Update
Counseling, Multiplex Testing May Lower Anxiety in At-Risk Patients with Cancer
Wayne Kuznar
TON March 2016 Vol 9 No 2
in
Genetic Counseling
Scalp Cooling System Lessens Chemotherapy-Induced Alopecia
Wayne Kuznar
TOP - February 2016, Vol 9, No 1
in
Breast Cancer
Oncology Medical Home Shows Significant Cost-Savings, Improved Care Delivery
Wayne Kuznar
TON January 2016 Vol 9 No 1
in
Navigation
Oncology Specialty Pharmacy Promotes the Coordination of Care
Wayne Kuznar
TOP November 2015 Vol 8 No 4
in
Practical Issues for Pharmacists
Molecular Pathways in Cancer Are Increasingly Being Exploited
Wayne Kuznar
TON November 2015 Vol 8 No 6
in
Personalized Medicine
Predictive Potential of Molecular Biomarkers Promises to Enhance Precision Medicine in Oncology
Wayne Kuznar
TON November 2015 Vol 8 No 6
in
Personalized Medicine
Immune Checkpoint Blockade Shows Durable Responses in Lung and Kidney Cancers, Metastatic Melanoma
Wayne Kuznar
TOP - August 2015, Vol 8, No 3
NCCN Issues New Smoking-Cessation Guidelines for Patients with Cancer
Wayne Kuznar
TOP - August 2015, Vol 8, No 3
in
Prevention
Treatment for CLL Will Incorporate More Targeted Therapies in the Near Future
Wayne Kuznar
TOP - August 2015, Vol 8, No 3
in
Hematologic Cancers
New NCCN Guideline Addresses Smoking Cessation in Patients With Cancer
Wayne Kuznar
TON May 2015 Vol 8 No 3
Vosaroxin, a Quinolone Derivative, Extends Survival in Older Patients with Acute Myeloid Leukemia
Wayne Kuznar
TOP - May 2015, Vol 8, No 2
in
Hematologic Cancers
Monitoring Response to TKI Therapy by PCR Improves Outcomes in Chronic Myeloid Leukemia
Wayne Kuznar
TOP - May 2015, Vol 8, No 2
in
Hematologic Cancers
Immunotherapy the Newest Breakthrough in Hodgkin Lymphoma
Wayne Kuznar
TOP - February 2015, Vol 8, No 1
in
Immunotherapy
Cancer Drug Pricing in the United States: What Is Driving the High Costs?
Wayne Kuznar
TOP - February 2015, Vol 8, No 1
in
Conference Correspondent
Routine Imaging Costly in B-Cell Lymphoma, Rarely Picks Up Relapse After Remission
Wayne Kuznar
TON - January 2015 Vol 8 No 1
in
Hematologic Cancers
Health Literacy
Wayne Kuznar
TOP - August 2014, Vol 7, No 3
in
Noteworthy Numbers
Worksite Pharmacy Can Enhance Overall Drug Management of Patients With Cancer
Wayne Kuznar
TOP - August 2014, Vol 7, No 3
in
Conference Correspondent
Exercise for Cancer Survivors
Wayne Kuznar
TON - July/August 2014 Vol 7 No 4
in
Conference Correspondent
Prospects for Personalization of Medicine Lie in Evidence Thresholds
Wayne Kuznar
TON - July/August 2014 Vol 7 No 4
in
Conference Correspondent
Skin Toxicity With Targeted Agents
Wayne Kuznar
TON - May/June 2014 Vol 7 No 3
in
Supportive Care
Skin Toxicity With Targeted Agents: Treatment With Antibiotics, Topical Steroids Often Sufficient
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Supportive Care
Molecular Monitoring Can Provide Treatment Guidance in CML
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Hematologic Cancers
Hormone Therapy Poses Health Risks in Patients With Prostate Cancer
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Hematologic Cancers
Molecular Therapy Beyond Sorafenib in HCC: New Pathways, Targets Being Explored
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Genitourinary Cancers
Promising Vaccine Combination Identified for Patients With Metastatic Pancreatic Cancer
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Rare Cancers
Immunotherapy Holds Promise to Extend Survival in GI Cancers
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Personalized Medicine
Investigational Angiogenesis Inhibitor Ramucirumab Improves Survival as Second-Line Treatment
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Gastrointestinal Cancers
Molecular Therapy Beyond Sorafenib in HCC: New Pathways, Targets Being Explored
Wayne Kuznar
TON - March/April 2014 Vol 7 No 2
in
Genitourinary Cancers
Prostate Cancer
Wayne Kuznar
TON - September 2013 Vol 6 No 8
in
Noteworthy Numbers
,
Hematologic Cancers
Novel Agents Emerge in Initial Therapy, Refractory Setting
Wayne Kuznar
TON - September 2013 Vol 6 No 8
in
Hematologic Cancers
Technology Brings No Upward Shift in Treatment of Local Prostate Cancer
Wayne Kuznar
TON - September 2013 Vol 6 No 8
in
Genitourinary Cancers
Monitor Adverse Events Early With Regorafenib, Especially After Initiation
Wayne Kuznar
TOP - May 2013, Vol 6, No 2
in
Supportive Care
Regorafenib Benefit in Colorectal Cancer Not Dependent on Mutations
Wayne Kuznar
TON - March 2013, Vol 6, No 2
in
Colorectal Cancer
Quality of Life Drives Patient Preference for Metastatic Renal Cell Carcinoma Drug
Wayne Kuznar
TOP - August 2012, Vol 5, No 5
Most End-of-Life Costs for Patients with Cancer Are Not Drug Related
Wayne Kuznar
TOP - September 2011 Vol 4, No 6
in
Conference Correspondent
Get Ready for the New Era of “Genomic Chaos” in Cancer Care
Wayne Kuznar
TOP - September 2011 Vol 4, No 6
in
Conference Correspondent
Decitabine Improves Overall Survival in Older AML Patients
Wayne Kuznar
TOP - August 2011 Vol 4, No 5
in
Conference Correspondent
,
Conference Correspondent
,
Hematologic Cancers
Timing of Empiric Antibiotic Administration Affects Outcomes in Febrile Neutropenia
Wayne Kuznar
TOP - February 2011, Vol 4, No 1
Last modified: June 10, 2010
Home
Issues
2019
April 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
2018
November 2018 - Vol 11 No 5
September 2018 - Vol 11 No 4
July 2018 - Vol 11 No 3
May 2018 - Vol 11 No 2
March 2018 - Vol 11 No 1
2017
November 2017 - Vol 10 No 6
September 2017 - Vol 10 No 5
July 2017 - Vol 10 No 4
May 2017 - Vol 10 No 3
March Vol 10 No 2
January Vol 10 No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ESMO 2018
ESMO 2018 Wrap-Up
HNF 2018
ASH 2017 - ITP
SABCS 2017 - Breast Cancer
ONS 2017 - Immunotherapy
ASH 2016 - Roundup
ASH 2016 - Multiple Myeloma
ASH 2015 - Multiple Myeloma
Web Exclusives
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Online First
Press Releases
Media Library
Videos
TON Interview with the Innovators Series
Audiocasts
Quick Quiz
CE
About
About TON
Contact Us
Editorial Board
Advertise
Resources
For Authors
Author Guidelines
